CINECA IRIS Institutional Research Information System

CAVALLO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.399
EU - Europa 8.163
AS - Asia 4.392
SA - Sud America 121
AF - Africa 108
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 18
Totale 25.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.129
IT - Italia 2.434
CN - Cina 2.429
IE - Irlanda 863
SE - Svezia 756
FR - Francia 707
DE - Germania 695
UA - Ucraina 567
SG - Singapore 539
FI - Finlandia 491
KR - Corea 428
GB - Regno Unito 391
PL - Polonia 294
VN - Vietnam 288
DK - Danimarca 250
AT - Austria 219
CA - Canada 196
JP - Giappone 193
IN - India 120
BE - Belgio 85
AU - Australia 77
SN - Senegal 77
TW - Taiwan 73
HK - Hong Kong 72
NL - Olanda 68
TR - Turchia 67
ES - Italia 60
MX - Messico 54
BR - Brasile 53
RU - Federazione Russa 51
IR - Iran 48
CH - Svizzera 36
GR - Grecia 29
NO - Norvegia 29
PT - Portogallo 28
CL - Cile 27
HU - Ungheria 22
CZ - Repubblica Ceca 21
ID - Indonesia 20
EU - Europa 18
MY - Malesia 18
CU - Cuba 16
RO - Romania 15
TH - Thailandia 15
LT - Lituania 14
UZ - Uzbekistan 13
PH - Filippine 12
AR - Argentina 11
EG - Egitto 11
PE - Perù 11
SA - Arabia Saudita 11
CO - Colombia 9
PK - Pakistan 9
BG - Bulgaria 8
EC - Ecuador 8
BY - Bielorussia 7
ZA - Sudafrica 7
MC - Monaco 6
IL - Israele 5
LB - Libano 5
MO - Macao, regione amministrativa speciale della Cina 5
RS - Serbia 5
NZ - Nuova Zelanda 4
SI - Slovenia 4
BD - Bangladesh 3
CY - Cipro 3
EE - Estonia 3
JO - Giordania 3
NG - Nigeria 3
SD - Sudan 3
SY - Repubblica araba siriana 3
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BT - Bhutan 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 25.282
Salva come PNG Salva come JPEG
Città #
Chandler 1.484
Beijing 1.125
Fairfield 1.037
Dublin 861
Houston 734
Ashburn 660
Ann Arbor 601
Torino 593
Wilmington 520
Woodbridge 506
Villeurbanne 429
Seattle 426
Jacksonville 422
Singapore 365
Cambridge 362
Princeton 293
Medford 284
Dearborn 280
Nyköping 275
Pisa 258
Warsaw 245
Turin 228
Vienna 194
Redwood City 172
Shanghai 164
Milan 154
Dong Ket 152
Fremont 133
Boston 117
Nanjing 111
Guangzhou 100
Boardman 87
New York 76
Rome 75
Toronto 70
Hangzhou 67
San Diego 63
Brussels 54
Ottawa 53
Chengdu 52
Taipei 49
Washington 49
Wuhan 49
Phoenix 48
Tokyo 45
Norwalk 44
Verona 44
Santa Clara 42
Falls Church 38
Hefei 38
Xian 38
Padova 37
Los Angeles 35
Helsinki 34
Silver Spring 34
Jinan 31
Changsha 30
Munich 29
Zhengzhou 29
Vigliano Biellese 26
Chongqing 25
Hong Kong 24
Seoul 24
Buffalo 23
Oslo 23
Shenyang 23
Kunming 22
Lachine 22
Philadelphia 22
Tianjin 22
Athens 21
Hebei 21
Sydney 21
London 19
Nanchang 19
Bologna 18
Duncan 18
Hyderabad 18
Pittsburgh 18
Pune 18
Upper Marlboro 18
Düsseldorf 17
Fuzhou 17
Mountain View 17
Radomsko 17
Santiago 17
Istanbul 16
Chennai 15
La Habana 15
Des Moines 14
San Mateo 14
Bethesda 13
Paris 13
Redmond 13
Evanston 12
Hamburg 12
Palermo 12
Utrecht 12
Villa Bartolomea 12
Ankara 11
Totale 15.359
Salva come PNG Salva come JPEG
Nome #
Breast cancer stem cell antigens as targets for immunotherapy 897
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination 577
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 429
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer. 422
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 388
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 371
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 342
The importance of comparative oncology in translational medicine. 331
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 312
Chondroitin sulfate proteoglycan 4: A biomarker and potential immunotherapeutic target for canine malignant melanoma 304
NK cells control breast cancer and related cancer stem cell hematological spread 294
Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment 271
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 267
State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? 263
Xenogene vaccination in the therapy of cancer. 261
CSPG4: a prototype oncoantigen for translational immunotherapy studies 258
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 247
Classification of current anticancer immunotherapies 244
Multi-level model for the investigation of oncoantigen- driven vaccination effect 236
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy 232
'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 231
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. 225
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results 222
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 211
State-of-the-Art Fusion-Finder Algorithms Sensitivity and Specificity 209
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 209
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 204
DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesis 192
The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2+ mammary cancer 192
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 192
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells 191
Cancer stem cell antigens as targets for new combined anti-cancer therapies 180
Consensus nomenclature for CD8(+) T cell phenotypes in cancer 175
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 174
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer 171
Ultra-sonophorated Oxygen-Loaded Nanobubbles effectively improve transcutaneous oxygenation in mice. 166
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 166
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 163
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells 162
Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging 160
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. 159
Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity 159
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 158
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 156
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 156
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 156
Ultrasound-activated decafluoropentane-cored and chitosan-shelled nanodroplets for oxygen delivery to hypoxic cutaneous tissues 154
Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis 152
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 151
Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer. 150
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study 150
Preclinical vaccines against mammary carcinoma 146
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model 143
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 137
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells 137
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 136
A plant-expressed conjugate vaccine breaks CD4+ tolerance and induces potent immunity against metastatic Her2+ breast cancer 135
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice 134
The Promise of Preventive Cancer Vaccines 133
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration 133
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy 133
ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult mice. 130
Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies. 128
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24–26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy 126
Novel insights into Notum and glypicans regulation in colorectal cancer 126
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 125
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 120
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 119
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway 117
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential 117
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 116
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 115
Multi-level model for the investigation of oncoantigen-driven vaccination effect 111
Immunotherapy and immunoprevention of cancer: where do we stand? 110
Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice 109
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 106
Immunological inhibition of carcinogenesis 104
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 104
Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. 102
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination 102
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions 101
Le difese immunitarie. 100
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 99
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins 95
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. 94
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity 93
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma 93
The role of cytokines in viral infections 92
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 91
2011: the immune hallmarks of cancer. 90
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 89
Vaccination to kitL: a new approach to inhibit tumor angiogenesis 89
A better immune reaction to Erbb-2 89
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. 88
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 88
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 88
Antitumor vaccines genetically engineered with cytokine gens 87
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy. 87
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention 87
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy 87
Totale 17.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.548
article - articoli 0
book - libri 0
conference - conferenze 6.017
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.798 0 0 307 542 360 613 460 298 457 299 232 230
2020/20213.447 221 234 299 164 265 208 305 194 450 359 242 506
2021/20223.456 200 186 164 268 190 198 261 187 187 320 633 662
2022/20234.677 495 327 92 468 459 1.118 375 316 511 123 242 151
2023/20242.381 284 301 173 137 188 303 146 173 30 147 205 294
2024/2025469 124 345 0 0 0 0 0 0 0 0 0 0
Totale 26.226